Lagerstroemia indica whole

Lagerstroemia indica whole is a botanical extract derived from the entire plant of the Indian Crape myrtle (*Lagerstroemia indica*). It is primarily marketed as a dietary supplement or herbal product, such as Chidangwon 300, which was first approved in 2013 by Yein Trading & Global Co., Ltd. The extract contains a diverse array of bioactive secondary metabolites, including alkaloids, cardiac glycosides, tannins, saponins, sterols, triterpenes, and flavonoids. While not an FDA-approved pharmaceutical drug, it has been traditionally used and scientifically studied for its potential anti-diabetic, anti-inflammatory, antioxidant, antimicrobial, and hepatoprotective properties. Its therapeutic effects are attributed to the synergistic action of its multiple chemical constituents rather than a single isolated active ingredient.

Brand names

Chidangwon 300Chidangwon300Chidangwon-300

Other names

Indian Crape myrtleLagerstroemia indica